Global Inherited Cancer Genome Testing Market Insights, Forecast to 2029

Inherited Cancer Genome Testing Market

Market Analysis and Insights: Global Inherited Cancer Genome Testing Market

The global Inherited Cancer Genome Testing market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Inherited Cancer Genome Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Inherited Cancer Genome Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Inherited Cancer Genome Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key companies of Inherited Cancer Genome Testing include 23andMe, Agilent Technologies, Bio-Rad Laboratories, Centogene, Color Genomics, Gene By Gene, Illumina, LabCorp and Myriad Genetics, etc. in 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes

This report presents an overview of global market for Inherited Cancer Genome Testing market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Inherited Cancer Genome Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Inherited Cancer Genome Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Inherited Cancer Genome Testing revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Inherited Cancer Genome Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Inherited Cancer Genome Testing revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including 23andMe, Agilent Technologies, Bio-Rad Laboratories, Centogene, Color Genomics, Gene By Gene, Illumina, LabCorp and Myriad Genetics, etc.

Scope of Inherited Cancer Genome Testing Market Report

Chapter Outline

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Inherited Cancer Genome Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Breast Cancer

1.2.3 Lung Cancer

1.2.4 Blood Cancer

1.2.5 Liver Cancer

1.2.6 Stomach Cancer

1.2.7 Others

1.3 Market by Application

1.3.1 Global Inherited Cancer Genome Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 General Hospitals

1.3.3 Specialty Clinics

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global Inherited Cancer Genome Testing Market Perspective (2018-2029)

2.2 Global Inherited Cancer Genome Testing Growth Trends by Region

2.2.1 Inherited Cancer Genome Testing Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Inherited Cancer Genome Testing Historic Market Size by Region (2018-2023)

2.2.3 Inherited Cancer Genome Testing Forecasted Market Size by Region (2024-2029)

2.3 Inherited Cancer Genome Testing Market Dynamics

2.3.1 Inherited Cancer Genome Testing Industry Trends

2.3.2 Inherited Cancer Genome Testing Market Drivers

2.3.3 Inherited Cancer Genome Testing Market Challenges

2.3.4 Inherited Cancer Genome Testing Market Restraints

3.1 Global Revenue Inherited Cancer Genome Testing by Players

3.1.1 Global Inherited Cancer Genome Testing Revenue by Players (2018-2023)

3.1.2 Global Inherited Cancer Genome Testing Revenue Market Share by Players (2018-2023)

3.2 Global Inherited Cancer Genome Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Inherited Cancer Genome Testing, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Inherited Cancer Genome Testing Market Concentration Ratio

3.4.1 Global Inherited Cancer Genome Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Inherited Cancer Genome Testing Revenue in 2022

3.5 Global Key Players of Inherited Cancer Genome Testing Head office and Area Served

3.6 Global Key Players of Inherited Cancer Genome Testing, Product and Application

3.7 Global Key Players of Inherited Cancer Genome Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Inherited Cancer Genome Testing Historic Market Size by Type (2018-2023)

4.2 Global Inherited Cancer Genome Testing Forecasted Market Size by Type (2024-2029)

5.1 Global Inherited Cancer Genome Testing Historic Market Size by Application (2018-2023)

5.2 Global Inherited Cancer Genome Testing Forecasted Market Size by Application (2024-2029)

6.1 North America Inherited Cancer Genome Testing Market Size (2018-2029)

6.2 North America Inherited Cancer Genome Testing Market Size by Type

6.2.1 North America Inherited Cancer Genome Testing Market Size by Type (2018-2023)

6.2.2 North America Inherited Cancer Genome Testing Market Size by Type (2024-2029)

6.2.3 North America Inherited Cancer Genome Testing Market Share by Type (2018-2029)

6.3 North America Inherited Cancer Genome Testing Market Size by Application

6.3.1 North America Inherited Cancer Genome Testing Market Size by Application (2018-2023)

6.3.2 North America Inherited Cancer Genome Testing Market Size by Application (2024-2029)

6.3.3 North America Inherited Cancer Genome Testing Market Share by Application (2018-2029)

6.4 North America Inherited Cancer Genome Testing Market Size by Country

6.4.1 North America Inherited Cancer Genome Testing Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Inherited Cancer Genome Testing Market Size by Country (2018-2023)

6.4.3 North America Inherited Cancer Genome Testing Market Size by Country (2024-2029)

6.4.4 United States

6.4.5 Canada

7.1 Europe Inherited Cancer Genome Testing Market Size (2018-2029)

7.2 Europe Inherited Cancer Genome Testing Market Size by Type

7.2.1 Europe Inherited Cancer Genome Testing Market Size by Type (2018-2023)

7.2.2 Europe Inherited Cancer Genome Testing Market Size by Type (2024-2029)

7.2.3 Europe Inherited Cancer Genome Testing Market Share by Type (2018-2029)

7.3 Europe Inherited Cancer Genome Testing Market Size by Application

7.3.1 Europe Inherited Cancer Genome Testing Market Size by Application (2018-2023)

7.3.2 Europe Inherited Cancer Genome Testing Market Size by Application (2024-2029)

7.3.3 Europe Inherited Cancer Genome Testing Market Share by Application (2018-2029)

7.4 Europe Inherited Cancer Genome Testing Market Size by Country

7.4.1 Europe Inherited Cancer Genome Testing Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Inherited Cancer Genome Testing Market Size by Country (2018-2023)

7.4.3 Europe Inherited Cancer Genome Testing Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8.1 China Inherited Cancer Genome Testing Market Size (2018-2029)

8.2 China Inherited Cancer Genome Testing Market Size by Type

8.2.1 China Inherited Cancer Genome Testing Market Size by Type (2018-2023)

8.2.2 China Inherited Cancer Genome Testing Market Size by Type (2024-2029)

8.2.3 China Inherited Cancer Genome Testing Market Share by Type (2018-2029)

8.3 China Inherited Cancer Genome Testing Market Size by Application

8.3.1 China Inherited Cancer Genome Testing Market Size by Application (2018-2023)

8.3.2 China Inherited Cancer Genome Testing Market Size by Application (2024-2029)

8.3.3 China Inherited Cancer Genome Testing Market Share by Application (2018-2029)

9.1 Asia Inherited Cancer Genome Testing Market Size (2018-2029)

9.2 Asia Inherited Cancer Genome Testing Market Size by Type

9.2.1 Asia Inherited Cancer Genome Testing Market Size by Type (2018-2023)

9.2.2 Asia Inherited Cancer Genome Testing Market Size by Type (2024-2029)

9.2.3 Asia Inherited Cancer Genome Testing Market Share by Type (2018-2029)

9.3 Asia Inherited Cancer Genome Testing Market Size by Application

9.3.1 Asia Inherited Cancer Genome Testing Market Size by Application (2018-2023)

9.3.2 Asia Inherited Cancer Genome Testing Market Size by Application (2024-2029)

9.3.3 Asia Inherited Cancer Genome Testing Market Share by Application (2018-2029)

9.4 Asia Inherited Cancer Genome Testing Market Size by Region

9.4.1 Asia Inherited Cancer Genome Testing Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Inherited Cancer Genome Testing Market Size by Region (2018-2023)

9.4.3 Asia Inherited Cancer Genome Testing Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10.1 Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Size by Type

10.2.1 Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Size by Application

10.3.1 Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Size by Country

10.4.1 Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11.1 23andMe

11.1.1 23andMe Company Details

11.1.2 23andMe Business Overview

11.1.3 23andMe Inherited Cancer Genome Testing Introduction

11.1.4 23andMe Revenue in Inherited Cancer Genome Testing Business (2018-2023)

11.1.5 23andMe Recent Developments

11.2 Agilent Technologies

11.2.1 Agilent Technologies Company Details

11.2.2 Agilent Technologies Business Overview

11.2.3 Agilent Technologies Inherited Cancer Genome Testing Introduction

11.2.4 Agilent Technologies Revenue in Inherited Cancer Genome Testing Business (2018-2023)

11.2.5 Agilent Technologies Recent Developments

11.3 Bio-Rad Laboratories

11.3.1 Bio-Rad Laboratories Company Details

11.3.2 Bio-Rad Laboratories Business Overview

11.3.3 Bio-Rad Laboratories Inherited Cancer Genome Testing Introduction

11.3.4 Bio-Rad Laboratories Revenue in Inherited Cancer Genome Testing Business (2018-2023)

11.3.5 Bio-Rad Laboratories Recent Developments

11.4 Centogene

11.4.1 Centogene Company Details

11.4.2 Centogene Business Overview

11.4.3 Centogene Inherited Cancer Genome Testing Introduction

11.4.4 Centogene Revenue in Inherited Cancer Genome Testing Business (2018-2023)

11.4.5 Centogene Recent Developments

11.5 Color Genomics

11.5.1 Color Genomics Company Details

11.5.2 Color Genomics Business Overview

11.5.3 Color Genomics Inherited Cancer Genome Testing Introduction

11.5.4 Color Genomics Revenue in Inherited Cancer Genome Testing Business (2018-2023)

11.5.5 Color Genomics Recent Developments

11.6 Gene By Gene

11.6.1 Gene By Gene Company Details

11.6.2 Gene By Gene Business Overview

11.6.3 Gene By Gene Inherited Cancer Genome Testing Introduction

11.6.4 Gene By Gene Revenue in Inherited Cancer Genome Testing Business (2018-2023)

11.6.5 Gene By Gene Recent Developments

11.7 Illumina

11.7.1 Illumina Company Details

11.7.2 Illumina Business Overview

11.7.3 Illumina Inherited Cancer Genome Testing Introduction

11.7.4 Illumina Revenue in Inherited Cancer Genome Testing Business (2018-2023)

11.7.5 Illumina Recent Developments

11.8 LabCorp

11.8.1 LabCorp Company Details

11.8.2 LabCorp Business Overview

11.8.3 LabCorp Inherited Cancer Genome Testing Introduction

11.8.4 LabCorp Revenue in Inherited Cancer Genome Testing Business (2018-2023)

11.8.5 LabCorp Recent Developments

11.9 Myriad Genetics

11.9.1 Myriad Genetics Company Details

11.9.2 Myriad Genetics Business Overview

11.9.3 Myriad Genetics Inherited Cancer Genome Testing Introduction

11.9.4 Myriad Genetics Revenue in Inherited Cancer Genome Testing Business (2018-2023)

11.9.5 Myriad Genetics Recent Developments

11.10 Positive Bioscience

11.10.1 Positive Bioscience Company Details

11.10.2 Positive Bioscience Business Overview

11.10.3 Positive Bioscience Inherited Cancer Genome Testing Introduction

11.10.4 Positive Bioscience Revenue in Inherited Cancer Genome Testing Business (2018-2023)

11.10.5 Positive Bioscience Recent Developments

11.11 Quest Diagnostics

11.11.1 Quest Diagnostics Company Details

11.11.2 Quest Diagnostics Business Overview

11.11.3 Quest Diagnostics Inherited Cancer Genome Testing Introduction

11.11.4 Quest Diagnostics Revenue in Inherited Cancer Genome Testing Business (2018-2023)

11.11.5 Quest Diagnostics Recent Developments

11.12 Thermo Fisher Scientific

11.12.1 Thermo Fisher Scientific Company Details

11.12.2 Thermo Fisher Scientific Business Overview

11.12.3 Thermo Fisher Scientific Inherited Cancer Genome Testing Introduction

11.12.4 Thermo Fisher Scientific Revenue in Inherited Cancer Genome Testing Business (2018-2023)

11.12.5 Thermo Fisher Scientific Recent Developments

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Inherited Cancer Genome Testing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

    Table 2. Key Players of Breast Cancer

    Table 3. Key Players of Lung Cancer

    Table 4. Key Players of Blood Cancer

    Table 5. Key Players of Liver Cancer

    Table 6. Key Players of Stomach Cancer

    Table 7. Key Players of Others

    Table 8. Global Inherited Cancer Genome Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

    Table 9. Global Inherited Cancer Genome Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 10. Global Inherited Cancer Genome Testing Market Size by Region (2018-2023) & (US$ Million)

    Table 11. Global Inherited Cancer Genome Testing Market Share by Region (2018-2023)

    Table 12. Global Inherited Cancer Genome Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 13. Global Inherited Cancer Genome Testing Market Share by Region (2024-2029)

    Table 14. Inherited Cancer Genome Testing Market Trends

    Table 15. Inherited Cancer Genome Testing Market Drivers

    Table 16. Inherited Cancer Genome Testing Market Challenges

    Table 17. Inherited Cancer Genome Testing Market Restraints

    Table 18. Global Inherited Cancer Genome Testing Revenue by Players (2018-2023) & (US$ Million)

    Table 19. Global Inherited Cancer Genome Testing Revenue Share by Players (2018-2023)

    Table 20. Global Top Inherited Cancer Genome Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inherited Cancer Genome Testing as of 2022)

    Table 21. Global Inherited Cancer Genome Testing Industry Ranking 2021 VS 2022 VS 2023

    Table 22. Global 5 Largest Players Market Share by Inherited Cancer Genome Testing Revenue (CR5 and HHI) & (2018-2023)

    Table 23. Global Key Players of Inherited Cancer Genome Testing, Headquarters and Area Served

    Table 24. Global Key Players of Inherited Cancer Genome Testing, Product and Application

    Table 25. Global Key Players of Inherited Cancer Genome Testing, Product and Application

    Table 26. Mergers & Acquisitions, Expansion Plans

    Table 27. Global Inherited Cancer Genome Testing Market Size by Type (2018-2023) & (US$ Million)

    Table 28. Global Inherited Cancer Genome Testing Revenue Market Share by Type (2018-2023)

    Table 29. Global Inherited Cancer Genome Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 30. Global Inherited Cancer Genome Testing Revenue Market Share by Type (2024-2029)

    Table 31. Global Inherited Cancer Genome Testing Market Size by Application (2018-2023) & (US$ Million)

    Table 32. Global Inherited Cancer Genome Testing Revenue Share by Application (2018-2023)

    Table 33. Global Inherited Cancer Genome Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 34. Global Inherited Cancer Genome Testing Revenue Share by Application (2024-2029)

    Table 35. North America Inherited Cancer Genome Testing Market Size by Type (2018-2023) & (US$ Million)

    Table 36. North America Inherited Cancer Genome Testing Market Size by Type (2024-2029) & (US$ Million)

    Table 37. North America Inherited Cancer Genome Testing Market Size by Application (2018-2023) & (US$ Million)

    Table 38. North America Inherited Cancer Genome Testing Market Size by Application (2024-2029) & (US$ Million)

    Table 39. North America Inherited Cancer Genome Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 40. North America Inherited Cancer Genome Testing Market Size by Country (2018-2023) & (US$ Million)

    Table 41. North America Inherited Cancer Genome Testing Market Size by Country (2024-2029) & (US$ Million)

    Table 42. Europe Inherited Cancer Genome Testing Market Size by Type (2018-2023) & (US$ Million)

    Table 43. Europe Inherited Cancer Genome Testing Market Size by Type (2024-2029) & (US$ Million)

    Table 44. Europe Inherited Cancer Genome Testing Market Size by Application (2018-2023) & (US$ Million)

    Table 45. Europe Inherited Cancer Genome Testing Market Size by Application (2024-2029) & (US$ Million)

    Table 46. Europe Inherited Cancer Genome Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Europe Inherited Cancer Genome Testing Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Europe Inherited Cancer Genome Testing Market Size by Country (2024-2029) & (US$ Million)

    Table 49. China Inherited Cancer Genome Testing Market Size by Type (2018-2023) & (US$ Million)

    Table 50. China Inherited Cancer Genome Testing Market Size by Type (2024-2029) & (US$ Million)

    Table 51. China Inherited Cancer Genome Testing Market Size by Application (2018-2023) & (US$ Million)

    Table 52. China Inherited Cancer Genome Testing Market Size by Application (2024-2029) & (US$ Million)

    Table 53. Asia Inherited Cancer Genome Testing Market Size by Type (2018-2023) & (US$ Million)

    Table 54. Asia Inherited Cancer Genome Testing Market Size by Type (2024-2029) & (US$ Million)

    Table 55. Asia Inherited Cancer Genome Testing Market Size by Application (2018-2023) & (US$ Million)

    Table 56. Asia Inherited Cancer Genome Testing Market Size by Application (2024-2029) & (US$ Million)

    Table 57. Asia Inherited Cancer Genome Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 58. Asia Inherited Cancer Genome Testing Market Size by Region (2018-2023) & (US$ Million)

    Table 59. Asia Inherited Cancer Genome Testing Market Size by Region (2024-2029) & (US$ Million)

    Table 60. Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Size by Type (2018-2023) & (US$ Million)

    Table 61. Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Size by Type (2024-2029) & (US$ Million)

    Table 62. Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Size by Application (2018-2023) & (US$ Million)

    Table 63. Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Size by Application (2024-2029) & (US$ Million)

    Table 64. Middle East, Africa, and Latin America Inherited Cancer Genome Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 65. Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Size by Country (2018-2023) & (US$ Million)

    Table 66. Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Size by Country (2024-2029) & (US$ Million)

    Table 67. 23andMe Company Details

    Table 68. 23andMe Business Overview

    Table 69. 23andMe Inherited Cancer Genome Testing Product

    Table 70. 23andMe Revenue in Inherited Cancer Genome Testing Business (2018-2023) & (US$ Million)

    Table 71. 23andMe Recent Developments

    Table 72. Agilent Technologies Company Details

    Table 73. Agilent Technologies Business Overview

    Table 74. Agilent Technologies Inherited Cancer Genome Testing Product

    Table 75. Agilent Technologies Revenue in Inherited Cancer Genome Testing Business (2018-2023) & (US$ Million)

    Table 76. Agilent Technologies Recent Developments

    Table 77. Bio-Rad Laboratories Company Details

    Table 78. Bio-Rad Laboratories Business Overview

    Table 79. Bio-Rad Laboratories Inherited Cancer Genome Testing Product

    Table 80. Bio-Rad Laboratories Revenue in Inherited Cancer Genome Testing Business (2018-2023) & (US$ Million)

    Table 81. Bio-Rad Laboratories Recent Developments

    Table 82. Centogene Company Details

    Table 83. Centogene Business Overview

    Table 84. Centogene Inherited Cancer Genome Testing Product

    Table 85. Centogene Revenue in Inherited Cancer Genome Testing Business (2018-2023) & (US$ Million)

    Table 86. Centogene Recent Developments

    Table 87. Color Genomics Company Details

    Table 88. Color Genomics Business Overview

    Table 89. Color Genomics Inherited Cancer Genome Testing Product

    Table 90. Color Genomics Revenue in Inherited Cancer Genome Testing Business (2018-2023) & (US$ Million)

    Table 91. Color Genomics Recent Developments

    Table 92. Gene By Gene Company Details

    Table 93. Gene By Gene Business Overview

    Table 94. Gene By Gene Inherited Cancer Genome Testing Product

    Table 95. Gene By Gene Revenue in Inherited Cancer Genome Testing Business (2018-2023) & (US$ Million)

    Table 96. Gene By Gene Recent Developments

    Table 97. Illumina Company Details

    Table 98. Illumina Business Overview

    Table 99. Illumina Inherited Cancer Genome Testing Product

    Table 100. Illumina Revenue in Inherited Cancer Genome Testing Business (2018-2023) & (US$ Million)

    Table 101. Illumina Recent Developments

    Table 102. LabCorp Company Details

    Table 103. LabCorp Business Overview

    Table 104. LabCorp Inherited Cancer Genome Testing Product

    Table 105. LabCorp Revenue in Inherited Cancer Genome Testing Business (2018-2023) & (US$ Million)

    Table 106. LabCorp Recent Developments

    Table 107. Myriad Genetics Company Details

    Table 108. Myriad Genetics Business Overview

    Table 109. Myriad Genetics Inherited Cancer Genome Testing Product

    Table 110. Myriad Genetics Revenue in Inherited Cancer Genome Testing Business (2018-2023) & (US$ Million)

    Table 111. Myriad Genetics Recent Developments

    Table 112. Positive Bioscience Company Details

    Table 113. Positive Bioscience Business Overview

    Table 114. Positive Bioscience Inherited Cancer Genome Testing Product

    Table 115. Positive Bioscience Revenue in Inherited Cancer Genome Testing Business (2018-2023) & (US$ Million)

    Table 116. Positive Bioscience Recent Developments

    Table 117. Quest Diagnostics Company Details

    Table 118. Quest Diagnostics Business Overview

    Table 119. Quest Diagnostics Inherited Cancer Genome Testing Product

    Table 120. Quest Diagnostics Revenue in Inherited Cancer Genome Testing Business (2018-2023) & (US$ Million)

    Table 121. Quest Diagnostics Recent Developments

    Table 122. Thermo Fisher Scientific Company Details

    Table 123. Thermo Fisher Scientific Business Overview

    Table 124. Thermo Fisher Scientific Inherited Cancer Genome Testing Product

    Table 125. Thermo Fisher Scientific Revenue in Inherited Cancer Genome Testing Business (2018-2023) & (US$ Million)

    Table 126. Thermo Fisher Scientific Recent Developments

    Table 127. Research Programs/Design for This Report

    Table 128. Key Data Information from Secondary Sources

    Table 129. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Inherited Cancer Genome Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 2. Global Inherited Cancer Genome Testing Market Share by Type: 2022 VS 2029

    Figure 3. Breast Cancer Features

    Figure 4. Lung Cancer Features

    Figure 5. Blood Cancer Features

    Figure 6. Liver Cancer Features

    Figure 7. Stomach Cancer Features

    Figure 8. Others Features

    Figure 9. Global Inherited Cancer Genome Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 10. Global Inherited Cancer Genome Testing Market Share by Application: 2022 VS 2029

    Figure 11. General Hospitals Case Studies

    Figure 12. Specialty Clinics Case Studies

    Figure 13. Inherited Cancer Genome Testing Report Years Considered

    Figure 14. Global Inherited Cancer Genome Testing Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Inherited Cancer Genome Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Inherited Cancer Genome Testing Market Share by Region: 2022 VS 2029

    Figure 17. Global Inherited Cancer Genome Testing Market Share by Players in 2022

    Figure 18. Global Top Inherited Cancer Genome Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inherited Cancer Genome Testing as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Inherited Cancer Genome Testing Revenue in 2022

    Figure 20. North America Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Inherited Cancer Genome Testing Market Share by Type (2018-2029)

    Figure 22. North America Inherited Cancer Genome Testing Market Share by Application (2018-2029)

    Figure 23. North America Inherited Cancer Genome Testing Market Share by Country (2018-2029)

    Figure 24. United States Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Canada Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Inherited Cancer Genome Testing Market Size YoY (2018-2029) & (US$ Million)

    Figure 27. Europe Inherited Cancer Genome Testing Market Share by Type (2018-2029)

    Figure 28. Europe Inherited Cancer Genome Testing Market Share by Application (2018-2029)

    Figure 29. Europe Inherited Cancer Genome Testing Market Share by Country (2018-2029)

    Figure 30. Germany Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. France Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. U.K. Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Italy Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Russia Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Nordic Countries Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. China Inherited Cancer Genome Testing Market Size YoY (2018-2029) & (US$ Million)

    Figure 37. China Inherited Cancer Genome Testing Market Share by Type (2018-2029)

    Figure 38. China Inherited Cancer Genome Testing Market Share by Application (2018-2029)

    Figure 39. Asia Inherited Cancer Genome Testing Market Size YoY (2018-2029) & (US$ Million)

    Figure 40. Asia Inherited Cancer Genome Testing Market Share by Type (2018-2029)

    Figure 41. Asia Inherited Cancer Genome Testing Market Share by Application (2018-2029)

    Figure 42. Asia Inherited Cancer Genome Testing Market Share by Region (2018-2029)

    Figure 43. Japan Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. South Korea Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. China Taiwan Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Southeast Asia Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. India Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Australia Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Size YoY (2018-2029) & (US$ Million)

    Figure 50. Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Share by Type (2018-2029)

    Figure 51. Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Share by Application (2018-2029)

    Figure 52. Middle East, Africa, and Latin America Inherited Cancer Genome Testing Market Share by Country (2018-2029)

    Figure 53. Brazil Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 54. Mexico Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 55. Turkey Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 56. Saudi Arabia Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 57. Israel Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 58. GCC Countries Inherited Cancer Genome Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 59. 23andMe Revenue Growth Rate in Inherited Cancer Genome Testing Business (2018-2023)

    Figure 60. Agilent Technologies Revenue Growth Rate in Inherited Cancer Genome Testing Business (2018-2023)

    Figure 61. Bio-Rad Laboratories Revenue Growth Rate in Inherited Cancer Genome Testing Business (2018-2023)

    Figure 62. Centogene Revenue Growth Rate in Inherited Cancer Genome Testing Business (2018-2023)

    Figure 63. Color Genomics Revenue Growth Rate in Inherited Cancer Genome Testing Business (2018-2023)

    Figure 64. Gene By Gene Revenue Growth Rate in Inherited Cancer Genome Testing Business (2018-2023)

    Figure 65. Illumina Revenue Growth Rate in Inherited Cancer Genome Testing Business (2018-2023)

    Figure 66. LabCorp Revenue Growth Rate in Inherited Cancer Genome Testing Business (2018-2023)

    Figure 67. Myriad Genetics Revenue Growth Rate in Inherited Cancer Genome Testing Business (2018-2023)

    Figure 68. Positive Bioscience Revenue Growth Rate in Inherited Cancer Genome Testing Business (2018-2023)

    Figure 69. Quest Diagnostics Revenue Growth Rate in Inherited Cancer Genome Testing Business (2018-2023)

    Figure 70. Thermo Fisher Scientific Revenue Growth Rate in Inherited Cancer Genome Testing Business (2018-2023)

    Figure 71. Bottom-up and Top-down Approaches for This Report

    Figure 72. Data Triangulation

    Figure 73. Key Executives Interviewed